Publications scientifiques Bordet

Publications scientifiques Bordet

  • Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 study.

  • Auteurs Papagiannis A, Majjaj S, Duhoux FP, Agostinetto E, Stanciu AM, Vanhulst T, Buisseret L, Larsimont D, Veys I, Paesmans M, Hammer TB, Awada A, Ameye L, Rothe F, Madriles F, Cash TP, Salgado R, Willard-Gallo K, Sotiriou C, Vuylsteke P, Neven P, Ignatiadis M
  • Revue Nat Commun
  • Date de publication 2025-11
Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 study.
  • The Breast International Group (BIG) Patient Partnership: Embedding meaningful patient involvement in the design and conduct of breast cancer clinical research.

  • Auteurs Caballero C, Adam V, Birta O, Meheus L, Needham J, Hodgdon C, Gilhams L, Biurrun C, MacKenzie M, Spanic T, Stobart H, Belhadi L, Maués J, Casas A, Schumacher-Wulf E, Straehle C, O'Reilly S, Cameron D, Piccart M, Bliss J, Chua B
  • Revue Breast
  • Date de publication 2025-11
The Breast International Group (BIG) Patient Partnership: Embedding meaningful patient involvement in the design and conduct of breast cancer clinical research.
  • Radiotherapy plus Long-term Adjuvant Androgen Deprivation with a Luteinizing Hormone-releasing Hormone Antagonist Versus Agonist in Patients with Very High-risk Localized or Locally Advanced Prostate Cancer: The EORTC GUCG-1414 Phase 3 Randomized Trial.

  • Auteurs Zilli T, Böhmer D, Roeder A, Lauffer D, Villafranca Iturre AE, Jové-Teixidó JJ, Supiot S, Latorzeff I, Dirix P, Otte FX, Francolini G, Roumeguère T, Simon JM, Fournier B, Fortpied C, Lara PC, Tombal B
  • Revue Eur Urol Oncol
  • Date de publication 2025-11
Radiotherapy plus Long-term Adjuvant Androgen Deprivation with a Luteinizing Hormone-releasing Hormone Antagonist Versus Agonist in Patients with Very High-risk Localized or Locally Advanced Prostate Cancer: The EORTC GUCG-1414 Phase 3 Randomized Trial.
  • Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis.

  • Auteurs Bregni G, Leurquin B, Giasafaki P, Takemura N, Kokudo N, Hasegawa K, Matsuyama Y, Nishioka Y, Aparicio T, Guimbaud R, Malicot KL, Tu D, O'Callaghan C, Lutz MP, Fontana E, Moehler M, Mauer ME, Sclafani F
  • Revue Eur J Cancer
  • Date de publication 2025-11
Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis.
Erasme hospital

Hôpital Erasme

Consultez toutes les publications scientifiques d'Erasme

Huderf hospital

Hôpital pédiatrique Reine Fabiola

Consultez toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola

Decorative image of doctor and patient

Toutes les publications scientifiques du H.U.B.

Consulter toutes les publications scientifiques du H.U.B.